Nearly 1 in 8 adults in the United States has used a GLP-1 drug, such as Ozempic or Mounjaro, according to new survey data from healthcare policy think tank KFF.
According to the survey, 12% of adults reported taking the revolutionary class of drugs to lose weight or treat chronic conditions, such as heart disease or obesity.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.